It is important to recognize that an EUA is not part of the development pathway; it is an entirely separate entity that is used only during emergency situations and is not part of the drug approval process. (2009 Institute of Medicine of the National Academies publication, p. 28)

All mRNA products on the market and in development today became available as a result of the declared Covid pandemic, through legal pathways intended for CBRN (chemical, biological, radiological, nuclear) emergencies – in other words, war or terror incidents involving weapons of mass destruction (WMD).

These WMD-related laws include Emergency Use Authorization (EUA) and blanket legal indemnity granted through the PREP Act.

The manufacturing agreements for the Covid mRNA vaccines were military Other Transaction Agreements (OTA) signed by the Pentagon. This type of "other than contract" agreement is intended to supply the military with cutting-edge technology while bypassing pesky regulations and red tape. It is not intended for civilian use.

No Regulatory Oversight = No Scientifically Valid Claims

These laws and contractual instruments do not require any regulatory oversight for the development, manufacture, distribution, or administration of countermeasures covered under the EUA and PREP Act. Any oversight activities, clinical investigations, or reporting of trial methods/practices/results are entirely voluntary on the part of the developers/manufacturers. 

In other words, any trials, inspections, experiments, or other activities carried out on these products do not have to comply with any safety standards, laws, or regulations that apply to the development of non-emergency medical products.